Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?

被引：2
|
作者：
Bertoli, Sarah [1 ]
Gadaud, Noemie [2 ]
Tavitian, Suzanne [1 ]
Sarry, Audrey [1 ]
Berard, Emilie [3 ,4 ]
Huguet, Francoise [1 ]
Recher, Christian [1 ,5 ]
机构：
[1] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[2] Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France
[3] CHU Toulouse, Serv Epidemiol, Toulouse, France
[4] Univ Toulouse 3, INSERM, UMR 1027, Toulouse, France
[5] CNRS, ERL5294, INSERM, UMR1037,Ctr Rech Cancerol Toulouse, Toulouse, France
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3991.3991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3991
引用
收藏
页数：5
相关论文
共 50 条
  • [1] TREATMENT OF RELAPSED ACUTE MYELOID-LEUKEMIA WITH IDARUBICIN AND INTERMEDIATE-DOSE CYTARABINE
    HAROUSSEAU, JL
    REIFFERS, J
    HURTELOUP, P
    MILPIED, N
    GUY, H
    RIGALHUGUET, F
    FACON, T
    DUFOUR, P
    IFRAH, N
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 45 - 49
  • [2] MITOXANTRONE AND INTERMEDIATE-DOSE CYTARABINE IN RELAPSED OR REFRACTORY ACUTE MYELOBLASTIC-LEUKEMIA
    HAROUSSEAU, JL
    MILPIED, N
    BRIERE, J
    DESABLENS, B
    GHANDOUR, C
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1990, 32 (04): : 227 - 230
  • [3] IDARUBICIN IN COMBINATION WITH INTERMEDIATE-DOSE CYTARABINE AND VP-16 IN THE TREATMENT OF REFRACTORY OR RAPIDLY RELAPSED PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    CARELLA, AM
    CARLIER, P
    PUNGOLINO, E
    RESEGOTTI, L
    LISO, V
    STASI, R
    MONTILLO, M
    IACOPINO, P
    MIRTO, S
    PAGANO, L
    LEONI, F
    MARTELLI, FM
    DIRAIMONDO, F
    PORCELLINI, A
    DERIU, L
    NOSARI, AM
    CIMINO, R
    DAMASIO, E
    MIRAGLIA, E
    FIORITONI, G
    RICCIUTI, F
    CAROTENUTO, M
    LONGINOTTI, M
    DEFAZIO, D
    FAZI, P
    MANDELLI, F
    LEUKEMIA, 1993, 7 (02) : 196 - 199
  • [4] Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia
    Sutoh, H
    Yamauchi, T
    Gotoh, N
    Sugiyama, M
    Ueda, T
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5037 - 5042
  • [5] IDARUBICIN IN COMBINATION WITH INTERMEDIATE-DOSE CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE LEUKEMIAS
    CARELLA, AM
    PUNGOLINO, E
    PIATTI, G
    GAOZZA, E
    NATI, S
    SPRIANO, M
    GIORDANO, D
    DAMICO, T
    DAMASIO, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (04) : 309 - 313
  • [6] Mitoxantrone and Etoposide with or without Intermediate-Dose Cytarabine for the Treatment of Patients with Primary Induction Failure or Relapsed Acute Myeloid Leukemia
    Trifilio, Steven
    Radamaker, Alfred
    Newman, Diane
    Coyle, Kathryn
    Leuer, Katrin Carlson
    Mehta, Jayesh
    Altman, Jessica Kaplan
    Frankfurt, Olga
    Tallman, Martin S.
    BLOOD, 2010, 116 (21) : 897 - 898
  • [7] Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia
    Bahng, H
    Lee, JH
    Ahn, JH
    Lee, JH
    Lee, JS
    Kim, SH
    Kim, WK
    Lee, KH
    LEUKEMIA RESEARCH, 2001, 25 (03) : 213 - 216
  • [8] Salvage chemotherapy with mitoxantrone, etoposide, and intermediate-dose cytarabine (MEC) in refractory or relapsed acute leukemia in adults.
    Jang, JH
    Lee, ST
    Hahn, JS
    Ko, YW
    Min, YH
    BLOOD, 2001, 98 (11) : 213B - 213B
  • [9] Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia
    Lee, Sung-Sook
    Lee, Je-Hwan
    Lee, Jung-Hee
    Kim, Dae-Young
    Kim, Se Hyung
    Lim, Sung-nam
    Lee, Young-Shin
    Seol, Miee
    Ryu, Seong-Gil
    Kang, Young-Ah
    Jang, Seongsoo
    Park, Chan-Jeoung
    Chi, Hyun-Sook
    Yun, Sung-Cheol
    Lee, Kyoo-Hyung
    LEUKEMIA RESEARCH, 2009, 33 (04) : 511 - 517
  • [10] Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia
    Lee, JH
    Choi, SJ
    Lee, JH
    Lee, YS
    Seol, M
    Ryu, SG
    Jang, S
    Park, CJ
    Chi, HS
    Lee, JS
    Kim, WK
    Lee, KH
    LEUKEMIA RESEARCH, 2006, 30 (02) : 204 - 210
12345